You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for Patent: 10,561,808


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,561,808 protect, and when does it expire?

Patent 10,561,808 protects PROAIR HFA, QVAR 40, QVAR 80, QVAR REDIHALER, PROAIR DIGIHALER, PROAIR RESPICLICK, AIRDUO DIGIHALER, AIRDUO RESPICLICK, ARMONAIR DIGIHALER, and ARMONAIR RESPICLICK, and is included in six NDAs.

Protection for AIRDUO DIGIHALER has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has one hundred and ninety-two patent family members in twenty-four countries.

Summary for Patent: 10,561,808
Title:Dose counter for inhaler having an anti-reverse rotation actuator
Abstract: A dose counter for an inhaler includes a counter display arranged to indicate dosage information, and a drive system arranged to move the counter display incrementally in a first direction from a first station to a second station in response to actuation input. A regulator is provided which is arranged to act upon the counter display at the first station to regulate motion of the counter display at the first station to incremental movements.
Inventor(s): Walsh; Declan (County Kilkenny, IE), Fenlon; Derek (County Wexford, IE), Kaar; Simon (County Cork, IE), Hazenberg; Jan Geert (County Kilkenny, IE), Buck; Daniel (County Waterford, IE), Clancy; Paul (Waterford, IE), Uschold; Robert Charles (Leominster, MA), Karg; Jeffrey A. (Hopkinton, MA)
Assignee: IVAX PHARMACEUTICALS IRELAND (Waterford, IE) NORTON (WATERFORD) LIMITED (Waterford, IE) TEVA PHARMACEUTICALS IRELAND (Waterford, IE)
Application Number:15/262,818
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,561,808
Patent Claim Types:
see list of patent claims
Delivery;

Drugs Protected by US Patent 10,561,808

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Teva Branded Pharm PROAIR HFA albuterol sulfate AEROSOL, METERED;INHALATION 021457-001 Oct 29, 2004 AB2 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm QVAR 80 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-001 Sep 15, 2000 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Norton Waterford QVAR REDIHALER beclomethasone dipropionate AEROSOL, METERED;INHALATION 207921-001 Aug 3, 2017 RX Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.